Filter News
Area of Research
News Type
News Topics
- (-) Coronavirus (11)
- 3-D Printing/Advanced Manufacturing (27)
- Advanced Reactors (5)
- Artificial Intelligence (12)
- Big Data (3)
- Bioenergy (15)
- Biology (9)
- Biomedical (17)
- Biotechnology (1)
- Buildings (5)
- Chemical Sciences (33)
- Clean Water (4)
- Climate Change (5)
- Composites (9)
- Computer Science (24)
- Critical Materials (13)
- Cybersecurity (5)
- Decarbonization (9)
- Energy Storage (38)
- Environment (21)
- Exascale Computing (2)
- Fossil Energy (1)
- Frontier (4)
- Fusion (8)
- Grid (5)
- High-Performance Computing (6)
- Hydropower (1)
- Irradiation (1)
- Isotopes (13)
- ITER (1)
- Machine Learning (7)
- Materials (80)
- Materials Science (87)
- Mathematics (1)
- Microscopy (27)
- Molten Salt (3)
- Nanotechnology (43)
- National Security (4)
- Net Zero (1)
- Neutron Science (107)
- Nuclear Energy (18)
- Partnerships (11)
- Physics (31)
- Polymers (18)
- Quantum Computing (4)
- Quantum Science (15)
- Renewable Energy (1)
- Security (3)
- Simulation (1)
- Space Exploration (5)
- Summit (6)
- Sustainable Energy (14)
- Transformational Challenge Reactor (3)
- Transportation (19)
Media Contacts
Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
Researchers from ORNL, the University of Tennessee at Chattanooga and Tuskegee University used mathematics to predict which areas of the SARS-CoV-2 spike protein are most likely to mutate.
Five technologies invented by scientists at the Department of Energy’s Oak Ridge National Laboratory have been selected for targeted investment through ORNL’s Technology Innovation Program.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
COVID-19 has upended nearly every aspect of our daily lives and forced us all to rethink how we can continue our work in a more physically isolated world.